OraSure Technologies Given New $8.00 Price Target at Cowen and Company (OSUR)
Research analysts at Cowen and Company lifted their price target on shares of OraSure Technologies (NASDAQ:OSUR) from $6.60 to $8.00 in a report released on Friday, Analyst Ratings Network.com reports. The firm currently has an “outperform” rating on the stock. Cowen and Company’s price target points to a potential upside of 36.75% from the company’s current price.
OraSure Technologies (NASDAQ:OSUR) traded down 0.17% on Friday, hitting $5.85. 312,775 shares of the company’s stock traded hands. OraSure Technologies has a 1-year low of $3.75 and a 1-year high of $11.00. The stock has a 50-day moving average of $5.51 and a 200-day moving average of $4.81. The company’s market cap is $325.2 million.
OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.10) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.16) by $0.06. The company had revenue of $24.30 million for the quarter, compared to the consensus estimate of $23.67 million. During the same quarter last year, the company posted ($0.07) earnings per share. OraSure Technologies’s revenue was up 7.5% compared to the same quarter last year. On average, analysts predict that OraSure Technologies will post $-0.47 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Raymond James upgraded shares of OraSure Technologies (NASDAQ:OSUR) from a “market perform” rating to an “outperform” rating in a research note to investors on Thursday, September 19th. They now have a $8.00 price target on the stock. Separately, analysts at Zacks downgraded shares of OraSure Technologies (NASDAQ:OSUR) from an “outperform” rating to a “neutral” rating in a research note to investors on Friday, September 6th. They now have a $5.60 price target on the stock. Finally, analysts at Zacks upgraded shares of OraSure Technologies (NASDAQ:OSUR) from a “neutral” rating to an “outperform” rating in a research note to investors on Thursday, August 8th. They now have a $5.30 price target on the stock. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $9.08.
OraSure Technologies, Inc, is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company’s oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.